[go: up one dir, main page]

AU7009387A - Membrane proteoglycans ribosomal vaccines - Google Patents

Membrane proteoglycans ribosomal vaccines

Info

Publication number
AU7009387A
AU7009387A AU70093/87A AU7009387A AU7009387A AU 7009387 A AU7009387 A AU 7009387A AU 70093/87 A AU70093/87 A AU 70093/87A AU 7009387 A AU7009387 A AU 7009387A AU 7009387 A AU7009387 A AU 7009387A
Authority
AU
Australia
Prior art keywords
membrane proteoglycans
proteoglycans
ribosomal
vaccines
ribosomal vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70093/87A
Inventor
Lucien Dussourd D'hinterland
Jacques Durand
Gerard Normier
Anne-Marie Pinel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU7009387A publication Critical patent/AU7009387A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to a process for preparing membrane proteoglycans of bacteria selected from: Klebsiella, Serratia and Corynebacterium, starting from a clarified lysate of the said bacterial strain, wherein a) the supernatant of the clarified lysate is treated with cetyltrimethylammonium or trichloroacetic acid, and b) after treatment, the supernatant containing the purified membrane proteoglycans is separated from the precipitated impurities.
AU70093/87A 1986-03-18 1987-03-17 Membrane proteoglycans ribosomal vaccines Abandoned AU7009387A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8603829 1986-03-18
FR8603829A FR2596064B1 (en) 1986-03-18 1986-03-18 INDUSTRIAL PROCESSES FOR THE MANUFACTURE OF RIBOSOMAL VACCINES AND RIBOSOMAL VACCINES OBTAINED

Publications (1)

Publication Number Publication Date
AU7009387A true AU7009387A (en) 1987-09-24

Family

ID=9333224

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70093/87A Abandoned AU7009387A (en) 1986-03-18 1987-03-17 Membrane proteoglycans ribosomal vaccines

Country Status (8)

Country Link
EP (1) EP0238407B1 (en)
JP (1) JPH01124396A (en)
AT (1) ATE79037T1 (en)
AU (1) AU7009387A (en)
DE (1) DE3780843T2 (en)
ES (1) ES2051759T3 (en)
FR (1) FR2596064B1 (en)
GR (1) GR3005567T3 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739382B1 (en) * 1995-09-28 1997-11-14 Oreal RIBOSOMAL FRACTION AND COMPOSITION CONTAINING THE SAME
DE19703437A1 (en) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Mixtures of outer membranes and / or cell walls of bacteria for oral immunization against mucosal infections
FR2790959B1 (en) * 1999-03-15 2003-06-27 Pf Medicament USE OF BACTERIAL MEMBRANARY FRACTIONS WITH ADJUVANT EFFECT, THEIR PREPARATION METHODS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2790960B1 (en) * 1999-03-15 2002-10-31 Pf Medicament USE OF BACTERIAL MEMBRANE FRACTIONS WITH IMMUNOSTIMULANT ACTIVITY IN THE TREATMENT OF CANCERS, THEIR PREPARATION METHODS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2790961B1 (en) * 1999-03-17 2001-06-22 Fabre Pierre Sante USE OF A COMPOSITION COMPRISING KLEBSIELLA PNEUMONIAE PROTEOGLYCANS, AND BACTERIAL RIBOSOMAL RIBOSOMES OR RNA FOR THE TREATMENT AND / OR PREVENTION OF PERIODONTAL DISEASES
GB9927493D0 (en) * 1999-11-19 2000-01-19 Boc Group Plc Improved vacuum pumps
GB2370838A (en) * 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex
JP7167576B2 (en) * 2018-09-14 2022-11-09 株式会社島津製作所 Method for preparing sample for analysis, method for analysis and method for identifying microorganisms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (en) * 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2305990A1 (en) * 1975-04-02 1976-10-29 Fabre Sa Pierre PREPARATION OF VACCINES BASED ON RNA NUCLEIC ACIDS ASSOCIATED WITH POLYSACCHARIDES EXTRACTED FROM MICROBIAL GERMS
FR2360314A2 (en) * 1976-08-06 1978-03-03 Fabre Sa Pierre NEW ADVANCED VACCINES BASED ON RIBOSOMAL FRACTIONS
FR2444464A1 (en) * 1978-12-19 1980-07-18 Fabre Sa Pierre PURIFIED BACTERIAL PROTEOGLYCANS, PROCESS FOR THEIR PREPARATION AND VACCINE CONTAINING THEM

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process

Also Published As

Publication number Publication date
GR3005567T3 (en) 1993-06-07
ATE79037T1 (en) 1992-08-15
DE3780843T2 (en) 1992-12-24
EP0238407A1 (en) 1987-09-23
EP0238407B1 (en) 1992-08-05
FR2596064B1 (en) 1990-02-02
ES2051759T3 (en) 1994-07-01
FR2596064A1 (en) 1987-09-25
JPH01124396A (en) 1989-05-17
DE3780843D1 (en) 1992-09-10

Similar Documents

Publication Publication Date Title
AU7009387A (en) Membrane proteoglycans ribosomal vaccines
ATE169224T1 (en) PEPTIDYL DERIVATIVES AND INHIBITORS OF THE INTERLEUKIN-1-G(B) CONVERTING ENZYME
ES8104412A1 (en) Process for the preparation of a purified protein hydrolysate
GR860571B (en) Labdan-derivatives process for their preparation and their use as medicaments
GB8820079D0 (en) Bacterial treatment to preserve hay quality by addition of microorganisms of genus bacillus
AU3526195A (en) Improved membrane
AU617318B2 (en) Outer membrane protein f of pseudomonas aeruginosa
AU585216B2 (en) Process for the microbiological preparation of l-carnitine
IL113595A0 (en) Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain
AU2158688A (en) Use of bezafibrate for treating diabetes
DK125887A (en) PROTECTION OF HORSES AGAINST STREPTOCOCCUS EQUI
NO885777D0 (en) PROCEDURE FOR PURIFICATION OF GRANULOCYTES / MACROPHAG COLONY STIMULATING FACTORS.
EP0234494A3 (en) Isohexide nucleosides, processes for their preparation and their use as medicaments
GR3003638T3 (en)
AU7293387A (en) Process for the treatment of milk for cheesemaking
AU7066287A (en) Pharmaceutical compositions containing 5-phenyl-1, 3-dioxoalkenyl compounds
AU660916B2 (en) Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours
AU586809B2 (en) Process for the preparation of a germ free solution of a lactose-splitting enzyme and its use.
DE3886234D1 (en) DNA sequences, plasmids and microorganisms as well as processes for the production of quinolinic acid.
GR74351B (en)
EP0189587A3 (en) Method of sterilizing recombinant microorganism
GR3003743T3 (en)
SU1367487A1 (en) Rabies vaccine production method
AU7728296A (en) Hemoregulatory compounds
AU1792788A (en) Rubradirin derivatives for treatment of hiv infection